Comprehensive cardiovascular magnetic resonance for evaluating structural myocardial changes in patients with hypertrophic obstructive cardiomyopathy treated with the first myosin inhibitor
K. Seuthe (Köln)
Zum Abstract
14:37
Diskussion
14:41
(V1252)
Optimizing Protocols for Regadenoson Stress CMR: Impact of Pause Duration Between Stress and Rest Perfusion on Rest Myocardial Blood Flow and Myocardial Perfusion Reserve
M. Lorenz (Stuttgart)
Zum Abstract
14:48
Diskussion
14:52
(V1253)
Assoziation einer frühen Nierenfunktionsstörung und MRT-basierter kardialer Schädigungsmuster
E. Cavus (Hamburg)
Zum Abstract
14:59
Diskussion
15:03
(V1254)
In Vitro Comparison of Blood Flow Characteristics in the Thoracic Aorta after Transcatheter and Rapid-Deployment Aortic Valve Replacement
C. Herz (München)
Zum Abstract
15:10
Diskussion
15:14
(V1255)
First Ultra-High-Field 19F MRI in large animal model after Acute Myocardial infarction at 7T MR-scanner
M. Hamid (Würzburg)
Zum Abstract
15:21
Diskussion
15:25
(V1256)
Atrial fibrillation is linked to prognostically significant left ventricular fibrosis and inflammation
J.-M. Treiber (Bad Nauheim)
Zum Abstract
15:32
Diskussion
15:36
(V1257)
Impact of cardiovascular risk factors on myocardial blood flow in patients with unobstructed coronary arteries: Results from the Stuttgart myocardial perfusion registry